Differentiated Thyroid Carcinoma in Pediatric Age Group/Differences in Diagnosis, Therapy and Follow-up
Journal Title: Nuclear Medicine Seminars - Year 2021, Vol 7, Issue 1
Abstract
Differentiated thyroid cancer in childhood is rare. Although its clinical course is quite aggressive with higher rates of lymph node and pulmonary metastases as compared to adults, the final outcome tends to be favorable. This is a review of the clinical picture, response to treatment and follow-up of differentiated thyroid cancer in children and young adolescents with main differences than adult differentiated thyroid cancer.
Authors and Affiliations
Pınar Özgen Kıratlı
Keywords
Related Articles
- EP ID EP693445
- DOI 10.4274/nts.galenos.2021.0011
- Views 80
- Downloads 0
Myocardial Perfusion SPECT Procedure Guideline
After Turkish Society of Nuclear Medicine “Cardiology Group” had first published “Nuclear Cardiology Practice Guidelines” in 2001, in line particular with the technological developments, significant changes both in the h...
How Use of Radioiodine Is Changing According to Risk Groups in Well Differentiated Thyroid Cancer?
Many aspects of patient management in thyroid cancers including I-131 use are based on retrospective data or expert opinions and still debatable. With the increasing use of ultrasonography, demographics of thyroid cancer...
Should the Place of Radioactive Iodine Whole Body Scintigraphy in Follow-up of Differentiated Thyroid Cancer Reevaluated in the Era of SPECT/CT?
Radioactive iodine scan is a quite specific method used for many years in differentiated thyroid cancer (DTC). However, combination of neck ultrasonography and serum thyroglobulin and anti-thyroglobulin has a high sensit...
Procedure Guideline for Detection of Inflammation with F-18 FDG PET/CT in Cardiac Sarcoidosis
Histologic confirmation of cardiac sarcoidosis (CS) is challenging. When taken into account of either the invasive nature or potential false negativity of the endomyocardial biopsy, imaging methods represent as a major a...
Current Good Manufacturing Practice for Radiopharmaceutical Products (GMPR)
Radiopharmaceutical products are classified as specialty medicinal products containing radionuclides whose half-lives range from a few minutes to several days, and therefore they form the basis of the same regulations as...